Global Antiemetic Drug Market 2026-2030

Publisher TechNavio

Published Feb 11, 2026

Length 305 Pages

SKU # INF20865480

Description

Global Antiemetic Drug Market 2026-2030

The global antiemetic drug market is forecasted to grow by USD 1918.6 mn during 2025-2030, accelerating at a CAGR of 6.4% during the forecast period. The report on the global antiemetic drug market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of cancer and demand for chemotherapy induced nausea, advancements in formulation technologies and delivery systems, expansion into non-oncology indications for motion sickness.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global antiemetic drug market is segmented as below:

By Drug Class

5-HT 3 receptor antagonist
Dopamine antagonist
NK 1 receptor antagonist
Cannabinoid receptor antagonist
Others

By Application

Chemotherapy
Surgery
Gastroenteritis
Others

By Route Of Administration

Injectable
Oral
Transdermal

Geography

North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Russia
Asia
Rest of World (ROW)
Rest of World (ROW)

This study identifies the increasing adoption of ready to use and long-acting injectable formulations as one of the prime reasons driving the global antiemetic drug market growth during the next few years. Also, strategic partnerships and acquisitions to expand portfolios and regulatory encouragement for multi mechanism will lead to sizable demand in the market.

The report on the global antiemetic drug market covers the following areas:

Global antiemetic drug market sizing
Global antiemetic drug market forecast
Global antiemetic drug market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global antiemetic drug market vendors that include Acacia Pharma Group Plc, Accord Healthcare Ltd., Astellas Pharma Inc., B.Braun SE, Baxter International Inc., Cadila Pharmaceuticals Ltd., Dr. Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Fresenius Kabi AG, GlaxoSmithKline Plc, Helsinn Healthcare SA, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sandoz Group AG, Sanofi SA, Sun Pharmaceutical Industries, Takeda Pharmaceutical Ltd., Teva Pharmaceutical Ltd., Viatris Inc.. Also, the global antiemetic drug market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market by Geography; Executive Summary - Chart on Market Segmentation by Drug Class; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Market Segmentation by Route of Administration; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Chart on Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Chart on Overview on factors of disruption; 2.4 Impact of drivers and challenges; Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape: 3.1 Market ecosystem; Chart on Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Chart on Market characteristics analysis; 3.3 Value chain analysis; Chart on Value chain analysis
4 Market Sizing: 4.1 Market definition; Data Table on Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2025; 4.4 Market outlook: Forecast for 2025-2030; Chart on Global - Market size and forecast 2025-2030 ($ million); Data Table on Global - Market size and forecast 2025-2030 ($ million); Chart on Global Market: Year-over-year growth 2025-2030 (%); Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size: 5.1 Global Antiemetic Drug Market 2020 - 2024; Historic Market Size - Data Table on Global Antiemetic Drug Market 2020 - 2024 ($ million); 5.2 Drug Class segment analysis 2020 - 2024; Historic Market Size - Drug Class Segment 2020 - 2024 ($ million); 5.3 Application segment analysis 2020 - 2024; Historic Market Size - Application Segment 2020 - 2024 ($ million); 5.4 Route of Administration segment analysis 2020 - 2024; Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million); 5.5 Geography segment analysis 2020 - 2024; Historic Market Size - Geography Segment 2020 - 2024 ($ million); 5.6 Country segment analysis 2020 - 2024; Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis: 6.1 Impact of AI on Global Antiemetic Drug Market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2025 and 2030; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2025 and 2030; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2025 and 2030; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2025 and 2030; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2025 and 2030; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2025 and 2030; 7.7 Market condition; Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Drug Class: 8.1 Market segments; Chart on Drug Class - Market share 2025-2030 (%); Data Table on Drug Class - Market share 2025-2030 (%); 8.2 Comparison by Drug Class; Chart on Comparison by Drug Class; Data Table on Comparison by Drug Class; 8.3 5-HT 3 receptor antagonist - Market size and forecast 2025-2030; Chart on 5-HT 3 receptor antagonist - Market size and forecast 2025-2030 ($ million); Data Table on 5-HT 3 receptor antagonist - Market size and forecast 2025-2030 ($ million); Chart on 5-HT 3 receptor antagonist - Year-over-year growth 2025-2030 (%); Data Table on 5-HT 3 receptor antagonist - Year-over-year growth 2025-2030 (%); 8.4 Dopamine antagonist - Market size and forecast 2025-2030; Chart on Dopamine antagonist - Market size and forecast 2025-2030 ($ million); Data Table on Dopamine antagonist - Market size and forecast 2025-2030 ($ million); Chart on Dopamine antagonist - Year-over-year growth 2025-2030 (%); Data Table on Dopamine antagonist - Year-over-year growth 2025-2030 (%); 8.5 NK 1 receptor antagonist - Market size and forecast 2025-2030; Chart on NK 1 receptor antagonist - Market size and forecast 2025-2030 ($ million); Data Table on NK 1 receptor antagonist - Market size and forecast 2025-2030 ($ million); Chart on NK 1 receptor antagonist - Year-over-year growth 2025-2030 (%); Data Table on NK 1 receptor antagonist - Year-over-year growth 2025-2030 (%); 8.6 Cannabinoid receptor antagonist - Market size and forecast 2025-2030; Chart on Cannabinoid receptor antagonist - Market size and forecast 2025-2030 ($ million); Data Table on Cannabinoid receptor antagonist - Market size and forecast 2025-2030 ($ million); Chart on Cannabinoid receptor antagonist - Year-over-year growth 2025-2030 (%); Data Table on Cannabinoid receptor antagonist - Year-over-year growth 2025-2030 (%); 8.7 Others - Market size and forecast 2025-2030; Chart on Others - Market size and forecast 2025-2030 ($ million); Data Table on Others - Market size and forecast 2025-2030 ($ million); Chart on Others - Year-over-year growth 2025-2030 (%); Data Table on Others - Year-over-year growth 2025-2030 (%); 8.8 Market opportunity by Drug Class; Market opportunity by Drug Class ($ million); Data Table on Market opportunity by Drug Class ($ million)
9 Market Segmentation by Application: 9.1 Market segments; Chart on Application - Market share 2025-2030 (%); Data Table on Application - Market share 2025-2030 (%); 9.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 9.3 Chemotherapy - Market size and forecast 2025-2030; Chart on Chemotherapy - Market size and forecast 2025-2030 ($ million); Data Table on Chemotherapy - Market size and forecast 2025-2030 ($ million); Chart on Chemotherapy - Year-over-year growth 2025-2030 (%); Data Table on Chemotherapy - Year-over-year growth 2025-2030 (%); 9.4 Surgery - Market size and forecast 2025-2030; Chart on Surgery - Market size and forecast 2025-2030 ($ million); Data Table on Surgery - Market size and forecast 2025-2030 ($ million); Chart on Surgery - Year-over-year growth 2025-2030 (%); Data Table on Surgery - Year-over-year growth 2025-2030 (%); 9.5 Gastroenteritis - Market size and forecast 2025-2030; Chart on Gastroenteritis - Market size and forecast 2025-2030 ($ million); Data Table on Gastroenteritis - Market size and forecast 2025-2030 ($ million); Chart on Gastroenteritis - Year-over-year growth 2025-2030 (%); Data Table on Gastroenteritis - Year-over-year growth 2025-2030 (%); 9.6 Others - Market size and forecast 2025-2030; Chart on Others - Market size and forecast 2025-2030 ($ million); Data Table on Others - Market size and forecast 2025-2030 ($ million); Chart on Others - Year-over-year growth 2025-2030 (%); Data Table on Others - Year-over-year growth 2025-2030 (%); 9.7 Market opportunity by Application; Market opportunity by Application ($ million); Data Table on Market opportunity by Application ($ million)
10 Market Segmentation by Route of Administration: 10.1 Market segments; Chart on Route of Administration - Market share 2025-2030 (%); Data Table on Route of Administration - Market share 2025-2030 (%); 10.2 Comparison by Route of Administration; Chart on Comparison by Route of Administration; Data Table on Comparison by Route of Administration; 10.3 Injectable - Market size and forecast 2025-2030; Chart on Injectable - Market size and forecast 2025-2030 ($ million); Data Table on Injectable - Market size and forecast 2025-2030 ($ million); Chart on Injectable - Year-over-year growth 2025-2030 (%); Data Table on Injectable - Year-over-year growth 2025-2030 (%); 10.4 Oral - Market size and forecast 2025-2030; Chart on Oral - Market size and forecast 2025-2030 ($ million); Data Table on Oral - Market size and forecast 2025-2030 ($ million); Chart on Oral - Year-over-year growth 2025-2030 (%); Data Table on Oral - Year-over-year growth 2025-2030 (%); 10.5 Transdermal - Market size and forecast 2025-2030; Chart on Transdermal - Market size and forecast 2025-2030 ($ million); Data Table on Transdermal - Market size and forecast 2025-2030 ($ million); Chart on Transdermal - Year-over-year growth 2025-2030 (%); Data Table on Transdermal - Year-over-year growth 2025-2030 (%); 10.6 Market opportunity by Route of Administration; Market opportunity by Route of Administration ($ million); Data Table on Market opportunity by Route of Administration ($ million)
11 Customer Landscape: 11.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape: 12.1 Geographic segmentation; Chart on Market share by geography 2025-2030 (%); Data Table on Market share by geography 2025-2030 (%); 12.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 12.3 North America - Market size and forecast 2025-2030; Chart on North America - Market size and forecast 2025-2030 ($ million); Data Table on North America - Market size and forecast 2025-2030 ($ million); Chart on North America - Year-over-year growth 2025-2030 (%); Data Table on North America - Year-over-year growth 2025-2030 (%); Chart on Regional Comparison - North America; Data Table on Regional Comparison - North America; 12.3.1 US - Market size and forecast 2025-2030; Chart on US - Market size and forecast 2025-2030 ($ million); Data Table on US - Market size and forecast 2025-2030 ($ million); Chart on US - Year-over-year growth 2025-2030 (%); Data Table on US - Year-over-year growth 2025-2030 (%); 12.3.2 Canada - Market size and forecast 2025-2030; Chart on Canada - Market size and forecast 2025-2030 ($ million); Data Table on Canada - Market size and forecast 2025-2030 ($ million); Chart on Canada - Year-over-year growth 2025-2030 (%); Data Table on Canada - Year-over-year growth 2025-2030 (%); 12.3.3 Mexico - Market size and forecast 2025-2030; Chart on Mexico - Market size and forecast 2025-2030 ($ million); Data Table on Mexico - Market size and forecast 2025-2030 ($ million); Chart on Mexico - Year-over-year growth 2025-2030 (%); Data Table on Mexico - Year-over-year growth 2025-2030 (%); 12.4 Europe - Market size and forecast 2025-2030; Chart on Europe - Market size and forecast 2025-2030 ($ million); Data Table on Europe - Market size and forecast 2025-2030 ($ million); Chart on Europe - Year-over-year growth 2025-2030 (%); Data Table on Europe - Year-over-year growth 2025-2030 (%); Chart on Regional Comparison - Europe; Data Table on Regional Comparison - Europe; 12.4.1 Germany - Market size and forecast 2025-2030; Chart on Germany - Market size and forecast 2025-2030 ($ million); Data Table on Germany - Market size and forecast 2025-2030 ($ million); Chart on Germany - Year-over-year growth 2025-2030 (%); Data Table on Germany - Year-over-year growth 2025-2030 (%); 12.4.2 UK - Market size and forecast 2025-2030; Chart on UK - Market size and forecast 2025-2030 ($ million); Data Table on UK - Market size and forecast 2025-2030 ($ million); Chart on UK - Year-over-year growth 2025-2030 (%); Data Table on UK - Year-over-year growth 2025-2030 (%); 12.4.3 France - Market size and forecast 2025-2030; Chart on France - Market size and forecast 2025-2030 ($ million); Data Table on France - Market size and forecast 2025-2030 ($ million); Chart on France - Year-over-year growth 2025-2030 (%); Data Table on France - Year-over-year growth 2025-2030 (%); 12.4.4 Italy - Market size and forecast 2025-2030; Chart on Italy - Market size and forecast 2025-2030 ($ million); Data Table on Italy - Market size and forecast 2025-2030 ($ million); Chart on Italy - Year-over-year growth 2025-2030 (%); Data Table on Italy - Year-over-year growth 2025-2030 (%); 12.4.5 Spain - Market size and forecast 2025-2030; Chart on Spain - Market size and forecast 2025-2030 ($ million); Data Table on Spain - Market size and forecast 2025-2030 ($ million); Chart on Spain - Year-over-year growth 2025-2030 (%); Data Table on Spain - Year-over-year growth 2025-2030 (%); 12.4.6 The Netherlands - Market size and forecast 2025-2030; Chart on The Netherlands - Market size and forecast 2025-2030 ($ million); Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million); Chart on The Netherlands - Year-over-year growth 2025-2030 (%); Data Table on The Netherlands - Year-over-year growth 2025-2030 (%); 12.4.7 Russia - Market size and forecast 2025-2030; Chart on Russia - Market size and forecast 2025-2030 ($ million); Data Table on Russia - Market size and forecast 2025-2030 ($ million); Chart on Russia - Year-over-year growth 2025-2030 (%); Data Table on Russia - Year-over-year growth 2025-2030 (%); 12.5 Asia - Market size and forecast 2025-2030; Chart on Asia - Market size and forecast 2025-2030 ($ million); Data Table on Asia - Market size and forecast 2025-2030 ($ million); Chart on Asia - Year-over-year growth 2025-2030 (%); Data Table on Asia - Year-over-year growth 2025-2030 (%); Chart on Regional Comparison - Asia; Data Table on Regional Comparison - Asia; 12.5.1 China - Market size and forecast 2025-2030; Chart on China - Market size and forecast 2025-2030 ($ million); Data Table on China - Market size and forecast 2025-2030 ($ million); Chart on China - Year-over-year growth 2025-2030 (%); Data Table on China - Year-over-year growth 2025-2030 (%); 12.5.2 Japan - Market size and forecast 2025-2030; Chart on Japan - Market size and forecast 2025-2030 ($ million); Data Table on Japan - Market size and forecast 2025-2030 ($ million); Chart on Japan - Year-over-year growth 2025-2030 (%); Data Table on Japan - Year-over-year growth 2025-2030 (%); 12.5.3 India - Market size and forecast 2025-2030; Chart on India - Market size and forecast 2025-2030 ($ million); Data Table on India - Market size and forecast 2025-2030 ($ million); Chart on India - Year-over-year growth 2025-2030 (%); Data Table on India - Year-over-year growth 2025-2030 (%); 12.5.4 South Korea - Market size and forecast 2025-2030; Chart on South Korea - Market size and forecast 2025-2030 ($ million); Data Table on South Korea - Market size and forecast 2025-2030 ($ million); Chart on South Korea - Year-over-year growth 2025-2030 (%); Data Table on South Korea - Year-over-year growth 2025-2030 (%); 12.5.5 Indonesia - Market size and forecast 2025-2030; Chart on Indonesia - Market size and forecast 2025-2030 ($ million); Data Table on Indonesia - Market size and forecast 2025-2030 ($ million); Chart on Indonesia - Year-over-year growth 2025-2030 (%); Data Table on Indonesia - Year-over-year growth 2025-2030 (%); 12.5.6 Thailand - Market size and forecast 2025-2030; Chart on Thailand - Market size and forecast 2025-2030 ($ million); Data Table on Thailand - Market size and forecast 2025-2030 ($ million); Chart on Thailand - Year-over-year growth 2025-2030 (%); Data Table on Thailand - Year-over-year growth 2025-2030 (%); 12.5.7 Singapore - Market size and forecast 2025-2030; Chart on Singapore - Market size and forecast 2025-2030 ($ million); Data Table on Singapore - Market size and forecast 2025-2030 ($ million); Chart on Singapore - Year-over-year growth 2025-2030 (%); Data Table on Singapore - Year-over-year growth 2025-2030 (%); 12.6 Rest of World (ROW) - Market size and forecast 2025-2030; Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%); Chart on Regional Comparison - Rest of World (ROW); Data Table on Regional Comparison - Rest of World (ROW); 12.6.1 Australia - Market size and forecast 2025-2030; Chart on Australia - Market size and forecast 2025-2030 ($ million); Data Table on Australia - Market size and forecast 2025-2030 ($ million); Chart on Australia - Year-over-year growth 2025-2030 (%); Data Table on Australia - Year-over-year growth 2025-2030 (%); 12.6.2 Brazil - Market size and forecast 2025-2030; Chart on Brazil - Market size and forecast 2025-2030 ($ million); Data Table on Brazil - Market size and forecast 2025-2030 ($ million); Chart on Brazil - Year-over-year growth 2025-2030 (%); Data Table on Brazil - Year-over-year growth 2025-2030 (%); 12.6.3 UAE - Market size and forecast 2025-2030; Chart on UAE - Market size and forecast 2025-2030 ($ million); Data Table on UAE - Market size and forecast 2025-2030 ($ million); Chart on UAE - Year-over-year growth 2025-2030 (%); Data Table on UAE - Year-over-year growth 2025-2030 (%); 12.6.4 South Africa - Market size and forecast 2025-2030; Chart on South Africa - Market size and forecast 2025-2030 ($ million); Data Table on South Africa - Market size and forecast 2025-2030 ($ million); Chart on South Africa - Year-over-year growth 2025-2030 (%); Data Table on South Africa - Year-over-year growth 2025-2030 (%); 12.6.5 Saudi Arabia - Market size and forecast 2025-2030; Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million); Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million); Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%); Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%); 12.6.6 Turkey - Market size and forecast 2025-2030; Chart on Turkey - Market size and forecast 2025-2030 ($ million); Data Table on Turkey - Market size and forecast 2025-2030 ($ million); Chart on Turkey - Year-over-year growth 2025-2030 (%); Data Table on Turkey - Year-over-year growth 2025-2030 (%); 12.7 Market opportunity by geography; Market opportunity by geography ($ million); Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity: 13.1 Market drivers; Rising prevalence of cancer and demand for chemotherapy induced nausea; Advancements in formulation technologies and delivery systems; Expansion into non-oncology indications for motion sickness; 13.2 Market challenges; Adverse effects and safety concerns associated with antiemetic drugs; Intense generic competition and price erosion; Management of breakthrough and refractory nausea; 13.3 Impact of drivers and challenges; Impact of drivers and challenges in 2025 and 2030; 13.4 Market opportunities; Increasing adoption of ready to use and long-acting injectable formulations; Strategic partnerships and acquisitions to expand portfolios; Regulatory encouragement for multi mechanism
14 Competitive Landscape: 14.1 Overview; 14.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 14.3 Landscape disruption; Overview on factors of disruption; 14.4 Industry risks; Impact of key risks on business
15 Competitive Analysis: 15.1 Companies profiled; Companies covered; 15.2 Company ranking index; Company ranking index; 15.3 Market positioning of companies; Matrix on companies position and classification; 15.4 B.Braun SE; B.Braun SE - Overview; B.Braun SE - Product / Service; B.Braun SE - Key news; B.Braun SE - Key offerings; SWOT; 15.5 Baxter International Inc.; Baxter International Inc. - Overview; Baxter International Inc. - Business segments; Baxter International Inc. - Key news; Baxter International Inc. - Key offerings; Baxter International Inc. - Segment focus; SWOT; 15.6 Cadila Pharmaceuticals Ltd.; Cadila Pharmaceuticals Ltd. - Overview; Cadila Pharmaceuticals Ltd. - Product / Service; Cadila Pharmaceuticals Ltd. - Key offerings; SWOT; 15.7 Dr. Reddys Laboratories Ltd.; Dr. Reddys Laboratories Ltd. - Overview; Dr. Reddys Laboratories Ltd. - Business segments; Dr. Reddys Laboratories Ltd. - Key news; Dr. Reddys Laboratories Ltd. - Key offerings; Dr. Reddys Laboratories Ltd. - Segment focus; SWOT; 15.8 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; SWOT; 15.9 Fresenius Kabi AG; Fresenius Kabi AG - Overview; Fresenius Kabi AG - Product / Service; Fresenius Kabi AG - Key offerings; SWOT; 15.10 Helsinn Healthcare SA; Helsinn Healthcare SA - Overview; Helsinn Healthcare SA - Product / Service; Helsinn Healthcare SA - Key offerings; SWOT; 15.11 Merck and Co. Inc.; Merck and Co. Inc. - Overview; Merck and Co. Inc. - Business segments; Merck and Co. Inc. - Key news; Merck and Co. Inc. - Key offerings; Merck and Co. Inc. - Segment focus; SWOT; 15.12 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; SWOT; 15.13 Sandoz Group AG; Sandoz Group AG - Overview; Sandoz Group AG - Product / Service; Sandoz Group AG - Key offerings; SWOT; 15.14 Sanofi SA; Sanofi SA - Overview; Sanofi SA - Business segments; Sanofi SA - Key news; Sanofi SA - Key offerings; Sanofi SA - Segment focus; SWOT; 15.15 Sun Pharmaceutical Industries; Sun Pharmaceutical Industries - Overview; Sun Pharmaceutical Industries - Product / Service; Sun Pharmaceutical Industries - Key news; Sun Pharmaceutical Industries - Key offerings; SWOT; 15.16 Takeda Pharmaceutical Ltd.; Takeda Pharmaceutical Ltd. - Overview; Takeda Pharmaceutical Ltd. - Product / Service; Takeda Pharmaceutical Ltd. - Key news; Takeda Pharmaceutical Ltd. - Key offerings; SWOT; 15.17 Teva Pharmaceutical Ltd.; Teva Pharmaceutical Ltd. - Overview; Teva Pharmaceutical Ltd. - Business segments; Teva Pharmaceutical Ltd. - Key news; Teva Pharmaceutical Ltd. - Key offerings; Teva Pharmaceutical Ltd. - Segment focus; SWOT; 15.18 Viatris Inc.; Viatris Inc. - Overview; Viatris Inc. - Business segments; Viatris Inc. - Key news; Viatris Inc. - Key offerings; Viatris Inc. - Segment focus; SWOT
16 Appendix: 16.1 Scope of the report; Market definition; Objectives; Notes and caveats; 16.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 16.3 Currency conversion rates for US$; Currency conversion rates for US$; 16.4 Research methodology; Research methodology; 16.5 Data procurement; Information sources; 16.6 Data validation; Data validation; 16.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 16.8 Data synthesis; Data synthesis; 16.9 360 degree market analysis; 360 degree market analysis; 16.10 List of abbreviations; List of abbreviations

Search Inside Report

Pricing

Currency Rates

Single User Online Download $2,500
Global Site License Online Download $4,000

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now